<?xml version="1.0" encoding="UTF-8"?><TimeML><TIMEX3 tid="t0" functionInDocument="CREATION_TIME"/>Japan's Yamanouchi Pharmaceutical Co. Ltd. <EVENT eid="e1" class="REPORTING" tense="PAST" aspect="NONE" polarity="POS" modality="none">said</EVENT>  <TIMEX3 tid="t1" type="DATE">Tuesday</TIMEX3> its <EVENT eid="e2" class="OCCURRENCE" tense="NONE" aspect="NONE" polarity="POS" modality="none">earnings</EVENT> would <EVENT eid="e3" class="STATE" tense="NONE" aspect="NONE" polarity="POS" modality="would">remain</EVENT> flat <TIMEX3 tid="t2" type="DATE">this year</TIMEX3> after group pre-tax profit  <EVENT eid="e4" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">rose</EVENT> 0.5 percent to 70 billion yen (680 million dollars) in <TIMEX3 tid="t3" type="DATE">the year</TIMEX3> to <TIMEX3 tid="t4" type="DATE">March</TIMEX3>.&#13;
The leading drugmaker <EVENT eid="e5" class="REPORTING" tense="PAST" aspect="NONE" polarity="POS" modality="none">said</EVENT> consolidated sales <EVENT eid="e6" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">grew</EVENT> 3.1 percent from <TIMEX3 tid="t5" type="DATE">a year  earlier</TIMEX3> to 369 billion yen, <EVENT eid="e7" class="OCCURRENCE" tense="PASTPART" aspect="NONE" polarity="POS" modality="none">supported</EVENT> by brisk sales of hormones and drugs for  stomach ulcers, circulatory diseases and cerebral hemorrhages.&#13;
Yamanouchi, which has a tie-up with Eli Lilly in the United States,  <EVENT eid="e8" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">forecast</EVENT> flat earnings of 70.5 billion yen <TIMEX3 tid="t6" type="DATE">this year</TIMEX3> on higher sales of 380  billion yen.&#13;
"We <EVENT eid="e9" class="I_STATE" tense="PRESENT" aspect="NONE" polarity="POS" modality="none">expect</EVENT> business conditions to be more severe in <TIMEX3 tid="t7" type="DATE">the current year</TIMEX3>, with  competition <EVENT eid="e10" class="OCCURRENCE" tense="PRESPART" aspect="NONE" polarity="POS" modality="none">intensifying</EVENT> as the medical business changes," a statement <EVENT eid="e11" class="REPORTING" tense="PAST" aspect="NONE" polarity="POS" modality="none">said</EVENT>.&#13;
Yamanouchi <EVENT eid="e12" class="REPORTING" tense="PAST" aspect="NONE" polarity="POS" modality="none">said</EVENT> parent company earnings, which <EVENT eid="e13" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">dropped</EVENT> 4.8 percent to 54.4  billion yen in the latest the year, were also <EVENT eid="e14" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">projected</EVENT> to <EVENT eid="e15" class="STATE" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="none">remain</EVENT> flat at 54.5  billion yen. Parent company sales, which <EVENT eid="e16" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">grew</EVENT> 6.6 percent to 260 billion yen,  were <EVENT eid="e17" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">forecast</EVENT> to <EVENT eid="e18" class="OCCURRENCE" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="none">rise</EVENT> modestly to around 265 billion yen.&#13;
Sales during <TIMEX3 tid="t9" type="DATE">the year</TIMEX3> were <EVENT eid="e19" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">buoyed</EVENT> by increased revenue from digestive  agents, hormones, urinary and reproductive agents, dermatological and blood  products and diagnostics, the company <EVENT eid="e20" class="REPORTING" tense="PAST" aspect="NONE" polarity="POS" modality="none">said</EVENT>.&#13;
But sales of nervous and sensory agents, circulatory and respiratory  agents, antibiotics and biological and metabolic agents <EVENT eid="e21" class="OCCURRENCE" tense="PAST" aspect="NONE" polarity="POS" modality="none">fell</EVENT>.&#13;
<TLINK relType="BEFORE" eventID="e1" relatedToTime="t0"/><TLINK relType="AFTER" eventID="e3" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e5" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e7" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e11" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e13" relatedToTime="t0"/><TLINK relType="AFTER" eventID="e15" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e17" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e19" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e21" relatedToTime="t0"/><TLINK relType="IS_INCLUDED" eventID="e1" relatedToTime="t2"/><TLINK relType="IS_INCLUDED" eventID="e1" relatedToTime="t4"/><TLINK relType="IS_INCLUDED" eventID="e2" relatedToTime="t2"/><TLINK relType="IS_INCLUDED" eventID="e2" relatedToTime="t4"/><TLINK relType="IS_INCLUDED" eventID="e3" relatedToTime="t2"/><TLINK relType="IS_INCLUDED" eventID="e3" relatedToTime="t4"/><TLINK relType="IS_INCLUDED" eventID="e4" relatedToTime="t2"/><TLINK relType="IS_INCLUDED" eventID="e4" relatedToTime="t4"/><TLINK relType="IS_INCLUDED" eventID="e8" relatedToTime="t6"/><TLINK relType="IS_INCLUDED" eventID="e11" relatedToTime="t7"/><TLINK relType="IS_INCLUDED" eventID="e19" relatedToTime="t9"/><TLINK relType="AFTER" eventID="e1" relatedToEvent="e2"/><TLINK relType="BEFORE" eventID="e2" relatedToEvent="e3"/><TLINK relType="AFTER" eventID="e5" relatedToEvent="e6"/><TLINK relType="BEFORE" eventID="e14" relatedToEvent="e15"/><TLINK relType="AFTER" eventID="e20" relatedToEvent="e19"/><TLINK relType="BEFORE" eventID="e17" relatedToEvent="e18"/><TLINK relType="AFTER" eventID="e12" relatedToEvent="e14"/><TLINK relType="AFTER" eventID="e3" relatedToEvent="e4"/><TLINK relType="BEFORE" eventID="e1" relatedToEvent="e3"/><TLINK relType="IS_INCLUDED" eventID="e20" relatedToTime="t9"/><TLINK relType="IS_INCLUDED" eventID="e13" relatedToTime="t8"/><TLINK relType="IS_INCLUDED" eventID="e9" relatedToTime="t7"/><TLINK relType="IS_INCLUDED" eventID="e5" relatedToTime="t5"/><TLINK relType="IS_INCLUDED" eventID="e4" relatedToTime="t3"/><TLINK relType="IS_INCLUDED" eventID="e4" relatedToTime="t1"/><TLINK relType="IS_INCLUDED" eventID="e3" relatedToTime="t3"/><TLINK relType="IS_INCLUDED" eventID="e3" relatedToTime="t1"/><TLINK relType="IS_INCLUDED" eventID="e2" relatedToTime="t3"/><TLINK relType="IS_INCLUDED" eventID="e2" relatedToTime="t1"/><TLINK relType="IS_INCLUDED" eventID="e1" relatedToTime="t3"/><TLINK relType="IS_INCLUDED" eventID="e1" relatedToTime="t1"/><TLINK relType="BEFORE" eventID="e20" relatedToTime="t0"/><TLINK relType="AFTER" eventID="e18" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e16" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e14" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e12" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e8" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e6" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e4" relatedToTime="t0"/><TLINK relType="BEFORE" eventID="e2" relatedToTime="t0"/></TimeML>